A functional genetic approach suggests a novel interaction between the human immunodeficiency virus type 1 (HIV-1) Tat protein and HIV-1 TAR RNA in vivo

被引：9
|
作者：
Lund, LH
Wahren, B
Garcia-Blanco, MA
机构：
[1] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[3] Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17182 Solna, Sweden
[4] Karolinska Inst, Swedish Inst Infect Dis Control, S-17182 Solna, Sweden
来源：
JOURNAL OF GENERAL VIROLOGY | 2003年 / 84卷
关键词：
D O I：
10.1099/vir.0.18645-0
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Human immunodeficiency virus type 1 (HIV-1) Tat and human Cyclin T1 form a complex and together recognize the viral TAR RNA element with specificity. Using HIV-1/equine infectious anaemia virus TAR chimeras, we show that in addition to the well-characterized interaction with the bulge, Tat recognizes the distal stem and the loop of TAR. These data support previously proposed, but unproven, molecular models.
引用
收藏
页码：603 / 606
页数：4
相关论文
共 50 条
  • [41] HIV-1 Tat interaction with Dicer: requirement for RNA
    Yamina Bennasser
    Kuan-Teh Jeang
    Retrovirology, 3
  • [42] Redox regulation of the human immunodeficiency virus type 1 (HIV-1).
    Piette, J
    Sappey, C
    Piret, B
    LegrandPoels, S
    DNA AND RNA CLEAVERS AND CHEMOTHERAPY OF CANCER AND VIRAL DISEASES, 1996, 479 : 249 - 268
  • [43] Human immunodeficiency virus type 1 (HIV-1) Vpr functions as an immediate-early protein during HIV-1 infection
    Hrimech, M
    Yao, XJ
    Bachand, F
    Rougeau, N
    Cohen, ÉA
    JOURNAL OF VIROLOGY, 1999, 73 (05) : 4101 - 4109
  • [44] Novel inhibitory factor(s) of human immunodeficiency virus type 1 (HIV-1) in amniotic fluid and in utero transmission of HIV-1
    Mato, SP
    Robinson, JE
    Amedee, AM
    Van Dyke, RB
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1092 - 1092
  • [45] Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatal HIV-1 transmission
    Panther, LA
    Tucker, L
    Xu, C
    Tuomala, RE
    Mullins, JI
    Anderson, DJ
    JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (02): : 555 - 563
  • [46] In vitro selection of HIV-1 TAR variants by the Tat protein
    Marozzi, A
    Meneveri, R
    Giacca, M
    Gutierrez, MI
    Siccardi, AG
    Ginelli, E
    JOURNAL OF BIOTECHNOLOGY, 1998, 61 (02) : 117 - 128
  • [47] Requirements for RNA heterodimerization of the human immunodeficiency virus type 1 (HIV-1) and HIV-2 genomes
    Dirac, AMG
    Huthoff, H
    Kjems, J
    Berkhout, B
    JOURNAL OF GENERAL VIROLOGY, 2002, 83 : 2533 - 2542
  • [48] Interaction of aminoglycoside antibiotics with HIV-1 TAR RNA
    Mei, HY
    Cui, M
    Czarnik, AW
    Lemrow, SM
    Truong, HN
    Loo, JA
    SannesLowery, KA
    Heldsinger, A
    Sharmeen, L
    Wang, S
    Huber, PW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 71 - CARB
  • [49] Oligonucleotide inhibition of the interaction of HIV-1 Tat protein with the trans-activation responsive region (TAR) of HIV RNA
    Mestre, B
    Arzumanov, A
    Singh, M
    Boulmé, F
    Litvak, S
    Gait, MJ
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1999, 1445 (01): : 86 - 98
  • [50] The Tat protein of human immunodeficiency virus type 1 (HIV-1) can promote placement of tRNA primer onto viral RNA and suppress later DNA polymerization in HIV-1 reverse transcription
    Kameoka, M
    Morgan, M
    Binette, M
    Russell, RS
    Rong, LW
    Guo, XF
    Mouland, A
    Kleiman, L
    Liang, C
    Wainberg, MA
    JOURNAL OF VIROLOGY, 2002, 76 (08) : 3637 - 3645
12345